Skip to main content

Table 4 Comparison of whole-body bone SPECT/CT results between PSA doubling time classes according to trigger PSA classes (p = 0.01 for global interaction)

From: Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

PSA ≤10 ng/ml, N = 87

Bone SPECT/CT result

Negative

(N = 74)

Positive

(N = 13)

OR (CI95)

p

 PSAdt > 6 months

49 (92.5)

4 (7.5)

reference

0.03

 PSAdt ≤6 months

25 (73.5)

9 (26.5)

4.4 (1.1–21.2)

PSA > 10 ng/ml, N = 28

Bone SPECT/CT result

Negative

(N = 14)

Positive

(N = 14)

OR (CI95)

p

 PSAdt > 6 months

4 (66.7)

2 (33.3)

reference

0.32

 PSAdt ≤6 months

10 (45.5)

12 (54.5)

2.4 (0.3–30.9)